Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 23/03/16
Trade details
- Type
- Insider sale
- Amount
- $739,343.39
- Shares · price
- 3,401 sh · $217.39 a share
- Held after
- 2,251 sh
- Trade date
- 23/03/15
- Filed
- 23/03/16
- Days to filing
- 1 days
Sold 60.2% of holdings
- Share of holding sold
- 60.2%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 23/02/13~23/04/14Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$220.2K
400 sh
$220.2K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$218.9K
400 sh
$218.9K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$153.5K
280 sh
$153.5K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$131.9K
240 sh
$131.9K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$114.8K
207 sh
$114.8K
Filed 10/01
Traded 09/30